CDK2 Inhibitors Prevent Noise-Induced Hearing Loss
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments lack effectiveness in preventing and treating noise-induced hearing loss (NIHL) and other forms of ototoxicity, such as cisplatin-induced hearing loss, despite promising preclinical and clinical safety studies.
Innovation Solution
Administration of a therapeutically effective amount of a cyclin-dependent kinase 2 (CDK2) inhibitor, or a pharmaceutically acceptable salt thereof, to prevent and treat hearing impairments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antioxidants and ROS scavengers are administered, then protective effects against hearing loss are expected, but effectiveness remains unclear despite promising preclinical studies
Solution Approach 1:
The patent transitions from testing multiple different antioxidant compounds to focusing on a specific compound (e.g., edaravone) and optimizing its dosage parameters. This parameter change approach resolves the contradiction by providing reliable effectiveness data through controlled dosage studies rather than continuing to test various compounds with uncertain outcomes
2Reliability
If CDK2 inhibitors are administered, then protective effects against noise-induced and cisplatin-induced hearing loss are demonstrated, but further clinical validation is needed
Solution Approach 1:
The patent conducts preclinical studies and establishes proof-of-concept in animal models before proceeding to clinical trials. This preliminary action with CDK2 inhibitors demonstrates protective effects against ototoxicity in controlled settings, creating a foundation for subsequent clinical validation and reducing the overall time required for comprehensive verification
Data Source
AI summary
In one aspect, pharmaceutical compositions comprising a CDK2 inhibitor and one or more of at least one agent known to treat a hearing impairment and at least one agent known to prevent a hearing impairment, and methods of treating and/or preventing hearing impairments or disorders using the compositions are disclosed. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.